RU2006137330A - Пероральные матричные композиции, содержащие ликарбазепин - Google Patents
Пероральные матричные композиции, содержащие ликарбазепин Download PDFInfo
- Publication number
- RU2006137330A RU2006137330A RU2006137330/15A RU2006137330A RU2006137330A RU 2006137330 A RU2006137330 A RU 2006137330A RU 2006137330/15 A RU2006137330/15 A RU 2006137330/15A RU 2006137330 A RU2006137330 A RU 2006137330A RU 2006137330 A RU2006137330 A RU 2006137330A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- licarbazepine
- composition according
- swellable substance
- oral
- Prior art date
Links
- BMPDWHIDQYTSHX-UHFFFAOYSA-N licarbazepine Chemical compound C1C(O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-UHFFFAOYSA-N 0.000 title claims 18
- 239000000203 mixture Substances 0.000 title claims 4
- 239000011159 matrix material Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 16
- 239000000126 substance Substances 0.000 claims 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 5
- 238000013270 controlled release Methods 0.000 claims 3
- 239000008203 oral pharmaceutical composition Substances 0.000 claims 3
- 208000019022 Mood disease Diseases 0.000 claims 2
- 229920003086 cellulose ether Polymers 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000008363 phosphate buffer Substances 0.000 claims 2
- 238000003756 stirring Methods 0.000 claims 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0406379A GB0406379D0 (en) | 2004-03-22 | 2004-03-22 | Organic compounds |
| GB0406379.8 | 2004-03-22 | ||
| GB0406738.5 | 2004-03-25 | ||
| GB0406738A GB0406738D0 (en) | 2004-03-25 | 2004-03-25 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006137330A true RU2006137330A (ru) | 2008-05-10 |
Family
ID=34961345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006137330/15A RU2006137330A (ru) | 2004-03-22 | 2005-03-21 | Пероральные матричные композиции, содержащие ликарбазепин |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070196488A1 (enExample) |
| EP (1) | EP1732519A1 (enExample) |
| JP (1) | JP2007529564A (enExample) |
| AR (1) | AR048318A1 (enExample) |
| AU (1) | AU2005226910B2 (enExample) |
| BR (1) | BRPI0509067A (enExample) |
| CA (1) | CA2558787A1 (enExample) |
| EC (1) | ECSP066860A (enExample) |
| IL (1) | IL177826A0 (enExample) |
| MA (1) | MA28527B1 (enExample) |
| MX (1) | MXPA06010810A (enExample) |
| NO (1) | NO20064808L (enExample) |
| PE (1) | PE20051156A1 (enExample) |
| RU (1) | RU2006137330A (enExample) |
| TW (1) | TW200534844A (enExample) |
| WO (1) | WO2005092294A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0221956D0 (en) * | 2002-09-20 | 2002-10-30 | Novartis Ag | Organic compounds |
| PE20060124A1 (es) * | 2004-03-22 | 2006-03-07 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
| US20060252745A1 (en) | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| ES2534514T3 (es) * | 2005-05-06 | 2015-04-23 | Bial-Portela & Ca, S.A. | Acetato de eslicarbazepina y métodos de uso |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| EP2683691B1 (en) | 2011-03-08 | 2018-06-06 | Jubilant Life Sciences Limited | PROCESS FOR THE PREPARATION OF (S)-(+)-10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ[b,f]AZEPINE-5-CARBOXAMIDE AND ESTERS THEREOF BY ENANTIOSELECTIVE REDUCTION OF 10,11-DIHYDRO-10-OXO-5H-DIBENZ[b,f]AZEPINE-5-CARBOXAMIDE |
| EP2498481A1 (en) | 2011-03-09 | 2012-09-12 | Sensirion AG | Mobile phone with humidity sensor |
| JP2013237676A (ja) * | 2013-06-26 | 2013-11-28 | Bial-Portela & Ca Sa | 酢酸エスリカルバゼピン及び使用方法 |
| ES2903037T3 (es) | 2015-12-18 | 2022-03-30 | Jubilant Generics Ltd | Formas de dosificación orales sólidas de eslicarbazepina |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US6296873B1 (en) * | 1997-01-23 | 2001-10-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Zero-order sustained release delivery system for carbamazephine derivatives |
| CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
| IL125244A (en) * | 1998-07-07 | 2002-12-01 | Yissum Res Dev Co | Pharmaceutical compositions containing low-melting waxes |
| MXPA04011801A (es) * | 2002-05-31 | 2005-09-12 | Desitin Arzneimittel Gmbh | Composicion farmaceutica que contiene oxcarbazepina con liberacion controlada de la substancia activa. |
| WO2004014391A1 (en) * | 2002-08-06 | 2004-02-19 | Novartis Ag | Use of carboxamides for the treatment of tinnitus |
| PE20060124A1 (es) * | 2004-03-22 | 2006-03-07 | Novartis Ag | Tabletas de desintegracion que comprenden licarbazepina |
-
2005
- 2005-03-18 AR ARP050101070A patent/AR048318A1/es unknown
- 2005-03-18 PE PE2005000316A patent/PE20051156A1/es not_active Application Discontinuation
- 2005-03-21 WO PCT/EP2005/002988 patent/WO2005092294A1/en not_active Ceased
- 2005-03-21 JP JP2007504334A patent/JP2007529564A/ja active Pending
- 2005-03-21 US US10/598,786 patent/US20070196488A1/en not_active Abandoned
- 2005-03-21 AU AU2005226910A patent/AU2005226910B2/en not_active Expired - Fee Related
- 2005-03-21 BR BRPI0509067-9A patent/BRPI0509067A/pt not_active IP Right Cessation
- 2005-03-21 RU RU2006137330/15A patent/RU2006137330A/ru not_active Application Discontinuation
- 2005-03-21 CA CA002558787A patent/CA2558787A1/en not_active Abandoned
- 2005-03-21 MX MXPA06010810A patent/MXPA06010810A/es not_active Application Discontinuation
- 2005-03-21 EP EP05716261A patent/EP1732519A1/en not_active Withdrawn
- 2005-03-21 TW TW094108532A patent/TW200534844A/zh unknown
-
2006
- 2006-08-31 IL IL177826A patent/IL177826A0/en unknown
- 2006-09-19 EC EC2006006860A patent/ECSP066860A/es unknown
- 2006-10-11 MA MA29380A patent/MA28527B1/fr unknown
- 2006-10-23 NO NO20064808A patent/NO20064808L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20051156A1 (es) | 2006-02-13 |
| BRPI0509067A (pt) | 2007-08-21 |
| IL177826A0 (en) | 2006-12-31 |
| ECSP066860A (es) | 2006-11-24 |
| EP1732519A1 (en) | 2006-12-20 |
| MXPA06010810A (es) | 2006-12-15 |
| TW200534844A (en) | 2005-11-01 |
| NO20064808L (no) | 2006-12-15 |
| CA2558787A1 (en) | 2005-10-06 |
| US20070196488A1 (en) | 2007-08-23 |
| AU2005226910B2 (en) | 2009-06-04 |
| AU2005226910A1 (en) | 2005-10-06 |
| MA28527B1 (fr) | 2007-04-03 |
| JP2007529564A (ja) | 2007-10-25 |
| AR048318A1 (es) | 2006-04-19 |
| WO2005092294A1 (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI113336B (fi) | Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen | |
| Alburyhi et al. | Formulation, Development and Evaluation of Famotidine Orodispersible Tablets | |
| KR100283709B1 (ko) | 안정한 서방성 경구 투여 조성물 | |
| US5571533A (en) | Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide | |
| WO2000037078A1 (de) | Kombination von cerivastatin und fibraten | |
| BG105665A (bg) | Лекарствена форма с контролирано освобождаване, съдържаща натриев дивалпроекс | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| RU2003100507A (ru) | Фармацевтические композиции | |
| PT85128B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona | |
| CY1653A (en) | Pharmaceutical compositions with analgesic properties and the preparation and use thereof | |
| RU2006137330A (ru) | Пероральные матричные композиции, содержащие ликарбазепин | |
| ES2547722T3 (es) | Formulación de liberación controlada para la administración oral de metformina | |
| WO2009152144A2 (en) | All day rhinitic condition treatment regimen | |
| AU780379B2 (en) | Orally distintegrating composition comprising mirtazapine | |
| JP2007529564A5 (enExample) | ||
| JP2006524190A (ja) | 薬剤のメントール溶液 | |
| US20060240101A1 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
| EP0521057A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL USES OF THESE COMPOSITIONS. | |
| JP3982889B2 (ja) | イブプロフェン含有医薬製剤 | |
| JP2005516943A (ja) | 経口投与に適した医薬品懸濁液 | |
| HU206268B (en) | Process for producing solid oral forms comprising iphosphamide as active ingredient | |
| JP4961338B2 (ja) | ナイアシンの経口投与用徐放性組成物 | |
| RU2006137329A (ru) | Распадающиеся таблетки, содержащие ликарбазепин | |
| CZ79593A3 (en) | Antitussive preparation | |
| CN1354662A (zh) | 奥桑唐特在用于治疗心情疾病的药物制剂中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090807 |